Compare NeoGenomics Inc. Common Stock (NEO) vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF (PDBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF — how do they compare? NeoGenomics Inc. Common Stock trades at $16.91 (market cap $2.17B), while Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF trades at $19.75 (market cap $7.97B). The key difference: Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF is far larger — about 3.7× NeoGenomics Inc. Common Stock's market cap, and Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF is trading nearer its 52-week high, NeoGenomics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF for 56 Days on average.
| NEO | PDBC | |
|---|---|---|
Market Cap | $2.17B | $7.97B |
Volume | 1,615,943 | 3,246,731 |
Sector | Health | — |
52-Week High | $19.91 | $20.10 |
52-Week Low | $7.19 | $13.19 |
Typical Hold Time | 0 Days | 56 Days |
Enterprise Value | $2.47B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PDBC, the Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF, trades at $19.98, up 0.6% on the day, with a strong bullish technical signal from moving averages. The ETF has delivered robust performance, rising 45.66% year-to-date through Q3 2026, driven by gains in energy and agricultural commodities amid geopolitical tensions. Institutional interest is growing, with several advisors increasing positions recently, though short interest also surged significantly in September.
The outlook for PDBC remains positive given ongoing commodity strength and defensive investor shifts, but risks include heightened short interest and geopolitical volatility that could pressure returns. Investors should weigh the ETF's momentum against potential pullbacks from overbought conditions and external shocks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Invesco Optimum Yld Dvsfd Cmd Str No K 1 ETF
The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a combination of financial instruments that are economically linked to the world's most heavily traded commodities. Commodities are assets that have tangible properties, such as oil, agricultural produce or raw metals.
Read more on PDBC →
